Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study. [electronic resource]
Producer: 20170621Description: 1246-1251 p. digitalISSN:- 1096-8652
- ADAMTS13 Protein -- blood
- Adult
- B-Lymphocytes -- drug effects
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Historically Controlled Study
- Humans
- Lymphocyte Depletion
- Male
- Middle Aged
- Plasma Exchange
- Platelet Count
- Purpura, Thrombotic Thrombocytopenic -- drug therapy
- Rituximab -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.